VYYRF News and Press, Voyageur Minerals Ltd From 03/04/24

--News Direct-- Calgary, Canada – TheNewswire - March 4, 2024 - Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) ("Voyageur" or the "Corporation") and Applied Pharmaceutical Innovation (API), a leading industry-funded not-for-profit organization driving life sciences commercializ...

(TheNewswire) Calgary, Canada / TheNewswire / March 1, 2024 - Voyageur Pharmaceuticals Ltd . ( TSX.V:VM ) (USA:VYYRF) ("Voyageur" or the "Company"), a provider of innovative medical imaging solutions, is pleased to announce it has closed its previously announced (Jan...

(TheNewswire) Calgary, Canada – TheNewswire - January16, 2024 - Voyageur Pharmaceuticals Ltd . ( TSXV:VM ) (USA:VYYRF) ("Voyageur" or the "Company"), a provider of innovative medical imaging solutions, is pleased to announce a proposed non-brokered private pla...

(TheNewswire) Calgary, Canada – TheNewswire - December 21, 2023 - Voyageur Pharmaceuticals Ltd . (TSXV:VM) ( OTC :VYYRF) ("Voyageur" or the "Corporation"), a provider of innovative medical imaging solutions, on December 19, 2023, it issued 590,735 Deferred Sha...

--News Direct-- Calgary, Canada - TheNewswire - December 21, 2023 - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (USA:VYYRF) ("Voyageur" or the "Corporation"), a provider of innovative medical imaging solutions, is excited to announce that its carbon capture and drug development partner, Rain Cag...

(NewsDirect) Voyageur Pharmaceuticals CEO Brent Willis joined Steve Darling from Proactive to discuss the recent announcement regarding its international expansion and third-party manufacturing for barium sulfate products in the radiology market marks a significant development for the com...

(TheNewswire) Calgary, Canada - TheNewswire - December 14, 2023 - Voyageur Pharmaceuticals Ltd. ( TSX.V:VM ) (USA:VYYRF) (" Voyageur " or the " Corporation "), a provider of innovative medical imaging solutions, is pleased to announce the form...

--News Direct-- Proactive Research Analyst Daniel Appiah speaks to Thomas Warner from the Londons studio after publishing a new research note on Canadian medical imaging contrast media company Voyageur Pharmaceuticals Ltd (TSX-V:VM) (OTC:VYYRF). Appiah gives an overview of the note an...

(TheNewswire) Calgary, Canada – TheNewswire - September 14, 2023 - Voyageur Pharmaceuticals Ltd . ( TSXV:VM ) ( USA : VYYRF) ("Voyageur" or the "Corporation"), a provider of innovative medical imaging solutions, is pleased to announce the completion of...

2023-08-03 11:04:20 ET Voyageur Pharmaceuticals press release ( OTCPK:VYYRF ): Q2 GAAP EPS of -$0.51. Revenue of $4.85M (+583.1% Y/Y). Voyager had collaboration revenue of $4.9 million for the second quarter of 2023, compared to $0.7 million for the sam...